Anisodamine Inhibits Thromboxane Synthesis, Granulocyte Aggregation, and Platelet Aggregation: A Possible Mechanism for Its Efficacy in Bacteremic Shock

Xiu Rui Juan, Patricia A. Coppo, Harry S. Jacob

Research output: Contribution to journalArticlepeer-review

51 Scopus citations

Abstract

Anisodamine hydrochloride is a vasoactive drug produced in the People's Republic of China that appears efficacious in clinical and experimental bacteremic shock, and about whose mode of action little is known. Suspecting that the drug might work by inhibition of platelet or granulocyte aggregation, or both, we tested it in these systems. Anisodamine proved a modest inhibitor of granulocyte aggregation and a powerful inhibitor of platelet aggregation; thromboxane synthesis was inhibited in anisodaminetreated platelets, further suggesting that the biochemical mode of action might be inhibition of cyclo-oxygenase or thromboxane synthetase. (JAMA 1982;247:1458-1460).

Original languageEnglish (US)
Pages (from-to)1458-1460
Number of pages3
JournalJAMA: The Journal of the American Medical Association
Volume247
Issue number10
DOIs
StatePublished - Mar 12 1982

Fingerprint

Dive into the research topics of 'Anisodamine Inhibits Thromboxane Synthesis, Granulocyte Aggregation, and Platelet Aggregation: A Possible Mechanism for Its Efficacy in Bacteremic Shock'. Together they form a unique fingerprint.

Cite this